Skip to content
healthcare.dev

Oxybutynin Chloride Extended Release

NDC 64980-209, Oxybutynin Chloride, tablet, extended release, from Rising Pharma Holdings, Inc..

Product NDC
64980-209
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206121
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64980-209 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYBUTYNIN CHLORIDE5 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
64980-209-0164980020901100 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-209-01)
64980-209-036498002090330 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-209-03)
64980-209-0564980020905500 TABLET, EXTENDED RELEASE in 1 BOTTLE (64980-209-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ab431781-3183-4638-b656-f40a61f07940
  • NADAC price for package 64980020901

    GET /v1/drugs/nadac/64980020901
  • NADAC price for package 64980020905

    GET /v1/drugs/nadac/64980020905

Use it

Look up 64980-209 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64980-209 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64980-209. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.